Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 33.51 (+0.99%)
AtriCure Reports First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 33.51 (+0.99%)
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 33.51 (+0.99%)
AtriCure to Announce First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 33.51 (+0.99%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar